SCHEMBL21921081

SCHEMBL21921081

CNCc1cccc2c1NCCC2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 1/20 0.44
ADORA1 P30542 1/20 0.44
SRC P12931 1/20 0.42
PARP1 P09874 3/20 0.39
SLC13A5 Q86YT5 1/20 0.34
REN P00797 1/20 0.34
AKT1 P31749 1/20 0.33
SLC6A4 P31645 4/20 0.33
HTR2A P28223 2/20 0.33
IFNAR1 P17181 1/20 0.33
TAAR1 Q96RJ0 1/20 0.33
F2 P00734 1/20 0.31
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
LMNA P02545 1/20 0.31
TP53 P04637 1/20 0.31
GAA P10253 1/20 0.31
MAPT P10636 1/20 0.31
THRB P10828 1/20 0.31
ALOX15 P16050 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9358469 0.81 SRC (0.49) ADORA2AADORA1SRCPARP1SLC13A5
SCHEMBL31310576 0.81 SRC (0.49) ADORA2AADORA1SRCPARP1SLC13A5
SCHEMBL10911692 0.79 SRC (0.43) ADORA2AADORA1SRCSLC13A5REN
SCHEMBL30487798 0.78 SRC (0.49) ADORA2AADORA1SRCSLC13A5REN
SCHEMBL9012495 0.78 SRC (0.49) ADORA2AADORA1SRCSLC13A5REN
SCHEMBL5542213 0.77 SRC (0.42) ADORA2AADORA1SRCSLC13A5REN
SCHEMBL5542208 0.77 SRC (0.49) ADORA2AADORA1SRCPARP1SLC13A5
SCHEMBL2093703 0.75 SRC (0.40) ADORA2AADORA1SRCSLC13A5REN
SCHEMBL28028253 0.75 SRC (0.45) ADORA2AADORA1SRCPARP1SLC13A5
SCHEMBL28690726 0.73 IAPP (0.45) ADORA2AADORA1SRCSLC13A5AKT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020063760-A1 NOVEL HETEROCYCLIC DERIVATIVES USEFUL AS SHP2 INHIBITORS JACOBIO PHARMACEUTICALS CO., LTD. (CN) 2020-04-02 WO disclosed